Logo image of BPYPO

BROOKFIELD PROPERTY PART - BPY 6 3/8 PERP (BPYPO) Stock Fundamental Analysis

NASDAQ:BPYPO - Nasdaq - BMG162491564 - Currency: USD

14.72  -0.19 (-1.27%)

Fundamental Rating

2

Overall BPYPO gets a fundamental rating of 2 out of 10. We evaluated BPYPO against 85 industry peers in the Chemicals industry. Both the profitability and financial health of BPYPO have multiple concerns. BPYPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BPYPO has reported negative net income.
In the past year BPYPO had a positive cash flow from operations.
BPYPO had negative earnings in 4 of the past 5 years.
BPYPO had a positive operating cash flow in 4 of the past 5 years.
BPYPO Yearly Net Income VS EBIT VS OCF VS FCFBPYPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

Looking at the Return On Assets, with a value of -0.50%, BPYPO is doing worse than 60.00% of the companies in the same industry.
BPYPO has a Return On Equity of -6.06%. This is in the lower half of the industry: BPYPO underperforms 64.71% of its industry peers.
With a Return On Invested Capital value of 3.30%, BPYPO is not doing good in the industry: 63.53% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for BPYPO is below the industry average of 7.02%.
The last Return On Invested Capital (3.30%) for BPYPO is above the 3 year average (3.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.5%
ROE -6.06%
ROIC 3.3%
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
BPYPO Yearly ROA, ROE, ROICBPYPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

BPYPO has a Operating Margin of 37.50%. This is amongst the best in the industry. BPYPO outperforms 98.82% of its industry peers.
BPYPO's Operating Margin has declined in the last couple of years.
The Gross Margin of BPYPO (53.64%) is better than 96.47% of its industry peers.
BPYPO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 37.5%
PM (TTM) N/A
GM 53.64%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
BPYPO Yearly Profit, Operating, Gross MarginsBPYPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BPYPO is destroying value.
Compared to 1 year ago, BPYPO has more shares outstanding
Compared to 5 years ago, BPYPO has less shares outstanding
Compared to 1 year ago, BPYPO has an improved debt to assets ratio.
BPYPO Yearly Shares OutstandingBPYPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BPYPO Yearly Total Debt VS Total AssetsBPYPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 4.37 is on the high side and indicates that BPYPO has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.37, BPYPO is doing worse than 89.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.37
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.6
WACC5.52%
BPYPO Yearly LT Debt VS Equity VS FCFBPYPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

2.3 Liquidity

A Current Ratio of 0.24 indicates that BPYPO may have some problems paying its short term obligations.
The Current ratio of BPYPO (0.24) is worse than 95.29% of its industry peers.
A Quick Ratio of 0.23 indicates that BPYPO may have some problems paying its short term obligations.
BPYPO has a worse Quick ratio (0.23) than 95.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.23
BPYPO Yearly Current Assets VS Current LiabilitesBPYPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

3. Growth

3.1 Past

The earnings per share for BPYPO have decreased by -8.59% in the last year.
The Revenue has decreased by -3.92% in the past year.
BPYPO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.12% yearly.
EPS 1Y (TTM)-8.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.53%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-23.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BPYPO Yearly Revenue VS EstimatesBPYPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
BPYPO Yearly EPS VS EstimatesBPYPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 0 1 -1 2 -2

0

4. Valuation

4.1 Price/Earnings Ratio

BPYPO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BPYPO Price Earnings VS Forward Price EarningsBPYPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

BPYPO's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.61
BPYPO Per share dataBPYPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 -500 1K -1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.93%, BPYPO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.77, BPYPO pays a better dividend. On top of this BPYPO pays more dividend than 98.82% of the companies listed in the same industry.
BPYPO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 10.93%

5.2 History

The dividend of BPYPO has a limited annual growth rate of 1.63%.
BPYPO has been paying a dividend for over 5 years, so it has already some track record.
The dividend of BPYPO decreased in the last 3 years.
Dividend Growth(5Y)1.63%
Div Incr Years0
Div Non Decr Years2
BPYPO Yearly Dividends per shareBPYPO Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BPYPO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-97.25%
EPS Next 2YN/A
EPS Next 3YN/A
BPYPO Yearly Income VS Free CF VS DividendBPYPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

BROOKFIELD PROPERTY PART - BPY 6 3/8 PERP

NASDAQ:BPYPO (5/28/2025, 8:21:52 PM)

14.72

-0.19 (-1.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap108.34M
Analysts46.67
Price TargetN/A
Short Float %0.56%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 10.93%
Yearly Dividend1.48
Dividend Growth(5Y)1.63%
DP-97.25%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-02 2025-06-02 (0.3984375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.11
P/B 0.01
P/tB 0.02
EV/EBITDA 13.61
EPS(TTM)-1.5
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1150.54
FCFYN/A
OCF(TTM)134.24
OCFY911.95%
SpS1237.91
BVpS1144.02
TBVpS895.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.5%
ROE -6.06%
ROCE 4.18%
ROIC 3.3%
ROICexc 3.39%
ROICexgc 3.47%
OM 37.5%
PM (TTM) N/A
GM 53.64%
FCFM N/A
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
ROICexc(3y)3.36%
ROICexc(5y)3.27%
ROICexgc(3y)3.45%
ROICexgc(5y)3.36%
ROCE(3y)4.09%
ROCE(5y)3.99%
ROICexcg growth 3Y-3.47%
ROICexcg growth 5Y2.52%
ROICexc growth 3Y-3.3%
ROICexc growth 5Y2.51%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 4.37
Debt/FCF N/A
Debt/EBITDA 9.59
Cap/Depr 2262.2%
Cap/Sales 103.79%
Interest Coverage 0.78
Cash Conversion 25.76%
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.23
Altman-Z N/A
F-Score4
WACC5.52%
ROIC/WACC0.6
Cap/Depr(3y)1344.37%
Cap/Depr(5y)1108.74%
Cap/Sales(3y)60.6%
Cap/Sales(5y)50.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-23.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.03%
EBIT growth 3Y3.96%
EBIT growth 5Y-1.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y247.24%
OCF growth 3Y17.7%
OCF growth 5Y9.63%